In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal Statistics, Q4 2014

A look at financing, M&A, and alliance activity October–December 2014

Executive Summary

Q4 device financing reached $902 million versus Q3’s $734 million, while device M&A dollar volume increased $19 billion, from Q3’s $4.9 billion. Diagnostics companies raised $750 million, an 85% rise over the previous quarter’s $405 million; although diagnostics M&A totaled just $1 billion, it was the most deal-active quarter of 2014 with 11 transactions.

Advertisement

Related Content

Neuromodulation Start-Ups: Abundant Funding, Slow Exits
Diagnostics In 2014: More Of The Same
Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Philips Increases Bet On Imaged-Guided Therapy With Volcano Buy
Abbott, NEA Show Medtech Deals Still Have Some Pop
Wright Moves More To Extremes With Tornier Purchase Agreement
Device/Diagnostics Quarterly Deal Statistics, Q4 2013
New Technologies Drive Growth In Orthopedic Extremities Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV004354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel